Martin Bowyer
12 May 2026
Clarity on the Updated Guidelines for ERA of Human Pharmaceuticals
European Medicines Agency provides Clarity on the Updated Guidelines for Environmental Risk Assessment of Human PharmaceuticalsTowards the end of 20...
05 May 2026
Environmental Risk Assessment of Generic Human Pharmaceuticals
Environmental Risk Assessment for Generics: Necessary Safeguard or Costly Box-Ticking?Environmental Risk Assessment (ERA) has long been part of phar...
Environmental Risk Assessment Service for Generic Human Medicinal ProductsGeneric pharmaceuticals are now under far greater scrutiny for their envir...
21 Mar 2025
Companies Affected by Changes to the EU’s Pharmaceutical Regulatory Framework
The legislative reforms, and specifically the changes relating to environmental risk assessments (ERAs) for pharmaceutical companies under the EU's ...
18 Feb 2025
Stringent Environmental Risk Assessments for Generic Drugs
As part of the broader legislative reforms under the EU's pharmaceutical regulatory framework – changes relating to environmental risk assessments (...
Martin Bowyer
Senior Regulatory Consultant | Specialist in Environmental Risk